349 research outputs found
VARIABILITY IN COMPETITIVE PERFORMANCE OF ELITE TRACK CYCLISTS
This study calculated the individual variation in performance times for cyclists competing in international track cycling events as Typical Error and attempted to express that variation in terms of power. Performance times were collated from six international events during the 2005/06 UCI Track Season and log transformed. Typical Error was calculated via the back transformation of the RMSE from a two-way ANOVA excluding the interaction term. The average Typical Error over all events was 1.0% (0.8 – 1.3 95% CL). Theoretically when performance is expressed as average power, the variation is approximately 3%. Modelling of power output for typical male and female pursuit cyclists appears to confirm this relationship under typical race conditions. These results can be used to assess the suitability of a field-based aerodynamic test for measuring the smallest worthwhile performance enhancing change in drag, whether a cyclist has shown worthwhile improvements in power during a laboratory performance test or in performance time during a competitive season
ANALYSIS OF PERFORMANCE OF THE KARATE PUNCH (GYAKU-ZUKI).
Variation in the movement sequence of the reverse punch (Gyaku-zuki) could affect kinematic variables such as punch time, distance and joint velocities. The reverse punches of nine elite Malaysian karate athletes were imaged in 3D at 150 Hz for two conditions (Jodan and Counter-chudan). Based on the linear resultant joint velocities of the shoulder and elbow two clusters are identified. One cluster is characterized by a more simultaneous movement sequence and the other by a more sequential movement sequence. The first cluster is mostly associated with female performances (87%) and the second cluster mostly with male performances (83%). It is found that the mostly male cluster achieved longer punch distance and higher peak linear resultant joint velocities for shoulder, elbow and wrist. Furthermore subgroups within the two clusters are identified and are associated with Jodan and Counter-chudan punches. The mostly female cluster achieves longer punch distance and higher peak linear resultant velocities in the subgroup associated with Jodan punches. However, the mostly male cluster achieves similar results for the subgroup associated with the Counter-chudan. Conclusion: the females tend to punch with a simultaneous sequence and men tend to punch with a sequential sequence with regard to the shoulder and elbow movements. Additionally women and men seem to have optimal performances in terms of punch distance and peak linear resultant joint velocities in different punching conditions
The challenge of measuring physical activity
Measuring physical activity accurately and reliably is essential when physical activity is
either an intervention or an outcome measure. Measurement of physical activity in population
groups has been undertaken in a number of ways, including self-report, observation, heart rate
measurement and activity monitors. The strengths and weaknesses of each of these methods will
be reviewed. The measurement of physical activity in children is an additional challenge and data
from the recently completed pilot study of the Kajian Aktiviti Fizikal dan Sukan Pelajar Sekolah Malaysia
2008 (KAFS08) will be used to illustrate these complexities. Questionnaire and activity monitoring
data were collected from 163 children attending four schools in Kuala Lumpur with an age range
of 9-18 years. Three models of activity monitors were used (YAMAX SW-700, OMRON HJ113,
ACTIGRAPH GT1M) and on completion of data collection, significant differences were found
between pedometer steps recorded on each monitor, after allowing for age and gender differences.
A subsequent study on the differences between the three monitors was undertaken involving over
15 individuals and over 40 days of measurement where one individual wore each of the three
monitors for a full day. In addition, the accuracy of each monitor was determined by comparing
the step count registered by the monitor with actual number of steps counted
On-Site Test of Filters in Nuclear Facilities using Radioactive Sodium Chloride (24Na)-Aerosol and Methyl Iodine (131I)
Recommended from our members
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.
Breast cancer is a common disease partially caused by genetic risk factors. Germline pathogenic variants in DNA repair genes BRCA1, BRCA2, PALB2, ATM, and CHEK2 are associated with breast cancer risk. FANCM, which encodes for a DNA translocase, has been proposed as a breast cancer predisposition gene, with greater effects for the ER-negative and triple-negative breast cancer (TNBC) subtypes. We tested the three recurrent protein-truncating variants FANCM:p.Arg658*, p.Gln1701*, and p.Arg1931* for association with breast cancer risk in 67,112 cases, 53,766 controls, and 26,662 carriers of pathogenic variants of BRCA1 or BRCA2. These three variants were also studied functionally by measuring survival and chromosome fragility in FANCM -/- patient-derived immortalized fibroblasts treated with diepoxybutane or olaparib. We observed that FANCM:p.Arg658* was associated with increased risk of ER-negative disease and TNBC (OR = 2.44, P = 0.034 and OR = 3.79; P = 0.009, respectively). In a country-restricted analysis, we confirmed the associations detected for FANCM:p.Arg658* and found that also FANCM:p.Arg1931* was associated with ER-negative breast cancer risk (OR = 1.96; P = 0.006). The functional results indicated that all three variants were deleterious affecting cell survival and chromosome stability with FANCM:p.Arg658* causing more severe phenotypes. In conclusion, we confirmed that the two rare FANCM deleterious variants p.Arg658* and p.Arg1931* are risk factors for ER-negative and TNBC subtypes. Overall our data suggest that the effect of truncating variants on breast cancer risk may depend on their position in the gene. Cell sensitivity to olaparib exposure, identifies a possible therapeutic option to treat FANCM-associated tumors
Recommended from our members
A network analysis to identify mediators of germline-driven differences in breast cancer prognosis.
Identifying the underlying genetic drivers of the heritability of breast cancer prognosis remains elusive. We adapt a network-based approach to handle underpowered complex datasets to provide new insights into the potential function of germline variants in breast cancer prognosis. This network-based analysis studies ~7.3 million variants in 84,457 breast cancer patients in relation to breast cancer survival and confirms the results on 12,381 independent patients. Aggregating the prognostic effects of genetic variants across multiple genes, we identify four gene modules associated with survival in estrogen receptor (ER)-negative and one in ER-positive disease. The modules show biological enrichment for cancer-related processes such as G-alpha signaling, circadian clock, angiogenesis, and Rho-GTPases in apoptosis
BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers
Background: The K3326X variant in BRCA2 (BRCA2*c.9976A>T; p.Lys3326*; rs11571833) has been found to be associated with small increased risks of breast cancer. However, it is not clear to what extent linkage disequilibrium with fully pathogenic mutations might account for this association. There is scant information about the effect of K3326X in other hormone-related cancers.
Methods: Using weighted logistic regression, we analyzed data from the large iCOGS study including 76 637 cancer case patients and 83 796 control patients to estimate odds ratios (ORw) and 95% confidence intervals (CIs) for K3326X variant carriers in relation to breast, ovarian, and prostate cancer risks, with weights defined as probability of not having a pathogenic BRCA2 variant. Using Cox proportional hazards modeling, we also examined the associations of K3326X with breast and ovarian cancer risks among 7183 BRCA1 variant carriers. All statistical tests were two-sided.
Results: The K3326X variant was associated with breast (ORw = 1.28, 95% CI = 1.17 to 1.40, P = 5.9x10- 6) and invasive ovarian cancer (ORw = 1.26, 95% CI = 1.10 to 1.43, P = 3.8x10-3). These associations were stronger for serous ovarian cancer and for estrogen receptor–negative breast cancer (ORw = 1.46, 95% CI = 1.2 to 1.70, P = 3.4x10-5 and ORw = 1.50, 95% CI = 1.28 to 1.76, P = 4.1x10-5, respectively). For BRCA1 mutation carriers, there was a statistically significant inverse association of the K3326X variant with risk of ovarian cancer (HR = 0.43, 95% CI = 0.22 to 0.84, P = .013) but no association with breast cancer. No association with prostate cancer was observed.
Conclusions: Our study provides evidence that the K3326X variant is associated with risk of developing breast and ovarian cancers independent of other pathogenic variants in BRCA2. Further studies are needed to determine the biological mechanism of action responsible for these associations
Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche.
Age at menarche is a marker of timing of puberty in females. It varies widely between individuals, is a heritable trait and is associated with risks for obesity, type 2 diabetes, cardiovascular disease, breast cancer and all-cause mortality. Studies of rare human disorders of puberty and animal models point to a complex hypothalamic-pituitary-hormonal regulation, but the mechanisms that determine pubertal timing and underlie its links to disease risk remain unclear. Here, using genome-wide and custom-genotyping arrays in up to 182,416 women of European descent from 57 studies, we found robust evidence (P < 5 × 10(-8)) for 123 signals at 106 genomic loci associated with age at menarche. Many loci were associated with other pubertal traits in both sexes, and there was substantial overlap with genes implicated in body mass index and various diseases, including rare disorders of puberty. Menarche signals were enriched in imprinted regions, with three loci (DLK1-WDR25, MKRN3-MAGEL2 and KCNK9) demonstrating parent-of-origin-specific associations concordant with known parental expression patterns. Pathway analyses implicated nuclear hormone receptors, particularly retinoic acid and γ-aminobutyric acid-B2 receptor signalling, among novel mechanisms that regulate pubertal timing in humans. Our findings suggest a genetic architecture involving at least hundreds of common variants in the coordinated timing of the pubertal transition
A new flowering time gene on wheat chromosome 3B characterization and genetic mapping
Genes that alter disease risk only in combination with certain environmental exposures may not be detected in genetic association analysis. By using methods accounting for gene-environment (G x E) interaction, we aimed to identify novel genetic loci associated with breast cancer risk. Up to 34,475 cases and 34,786 controls of European ancestry from up to 23 studies in the Breast Cancer Association Consortium were included. Overall, 71,527 single nucleotide polymorphisms (SNPs), enriched for association with breast cancer, were tested for interaction with 10 environmental risk factors using three recently proposed hybrid methods and a joint test of association and interaction. Analyses were adjusted for age, study, population stratification, and confounding factors as applicable. Three SNPs in two independent loci showed statistically significant association: SNPs rs10483028 and rs2242714 in perfect linkage disequilibrium on chromosome 21 and rs12197388 in ARID1B on chromosome 6. While rs12197388 was identified using the joint test with parity and with age at menarche (P-values = 3 x 10(-07)), the variants on chromosome 21 q22.12, which showed interaction with adult body mass index (BMI) in 8,891 postmenopausal women, were identified by all methods applied. SNP rs10483028 was associated with breast cancer in women with a BMI below 25 kg/m(2) (OR = 1.26, 95% CI 1.15-1.38) but not in women with a BMI of 30 kg/m(2) or higher (OR = 0.89, 95% CI 0.72-1.11, P for interaction = 3.2 x 10(-05)). Our findings confirm comparable power of the recent methods for detecting G x E interaction and the utility of using G x E interaction analyses to identify new susceptibility loci
Breast cancer risk genes: association analysis in more than 113,000 women
Item does not contain fulltex
- …